Chicago, IL, United States of America

Deborah Milkowski

This inventor holds 1 USPTO granted patent. Top assignee: Tap Pharmaceutical Products Inc.. Active years: 2003.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Deborah Milkowski. Retrieved from https://idiyas.com/inventor/deborah-milkowski

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


Average Co-Inventor Count = 3.0

ph-index = 1

Forward Citations = 11(Granted Patents)


Company Filing History:


Years Active: 2003

Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovations of Deborah Milkowski

Introduction

Deborah Milkowski is a notable inventor based in Chicago, IL (US). She has made significant contributions to the field of pharmaceuticals, particularly in the development of apomorphine derivatives. Her work focuses on enhancing the effectiveness of treatments for sexual dysfunction.

Latest Patents

Deborah Milkowski holds 1 patent for her invention titled "Apomorphine derivatives and methods for their use." This patent discloses apomorphine derivative compounds, which include pharmaceutically active compositions. The derivatives may take various forms such as esters, ethers, amides, mixed anhydrides, hemiacetals, glucuronates, sulfates, or phosphonates. A preferred derivative identified in her patent is norapomorphine.

Career Highlights

Deborah has been associated with Tap Pharmaceutical Products Inc., where she has utilized her expertise to advance pharmaceutical innovations. Her work has contributed to the development of new treatment methods that enhance patient care.

Collaborations

Throughout her career, Deborah has collaborated with notable colleagues, including Pramod Gupta and Debra Sutkowski-Markmann. These partnerships have fostered a collaborative environment that encourages innovation and the sharing of ideas.

Conclusion

Deborah Milkowski's contributions to the field of pharmaceuticals through her innovative work on apomorphine derivatives highlight her role as a significant inventor. Her dedication to improving treatment methods continues to impact the industry positively.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…